go-v.orgcodex
Menu
Page tools

codex · Chemistry

THAZ

Diagram for THAZ
THAZ, also known as 5,6,7,8-tetrahydro-4H-isoxazolo(4,5-d)azepin-3-ol, is a moderately potent GABAA-ρ receptor antagonist related to gaboxadol (THIP). Unlike gaboxadol, it is said to be virtually inactive at the GABAA receptor. However, in other studies, it showed significant affinity for the GABAA · image: Wikimedia Commons

THAZ, also known as 5,6,7,8-tetrahydro-4H-isoxazolo(4,5-d)azepin-3-ol, is a moderately potent GABAA-ρ receptor antagonist related to gaboxadol (THIP). Unlike gaboxadol, it is said to be virtually inactive at the GABAA receptor. However, in other studies, it showed significant affinity for the GABAA receptor, where it appeared to act as an antagonist. In addition to its GABAA-ρ receptor antagonism, THAZ is a very weak glycine receptor antagonist. In contrast to muscimol and gaboxadol, THAZ injected directly into the brain produced convulsions. The drug was first described in the scientific literature by Povl Krogsgaard-Larsen and colleagues by 1979.

Derivatives of THAZ such as N-Bn-THAZ and O-Bn-THAZ have been found to act as serotonin 5-HT2A and 5-HT2C receptor agonists.

Wikipedia contributors, "THAZ", Wikipedia, revision 1328699648, retrieved 20 November 2026, source, CC BY-SA 4.0.

More Chemistry · Search the codex